Genomictree Inc. (228760) — Capital Reinvestment Ratio
Genomictree Inc. (228760) has a Capital Reinvestment Ratio of 0.43x as of December 2022, meaning it reinvests 0% of its operating cash flow (₩4.29 Billion) in capital expenditures (₩1.82 Billion). See Genomictree Inc. balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genomictree Inc. Capital Reinvestment Ratio (2022–2022)
This chart tracks Genomictree Inc.'s Capital Reinvestment Ratio across 1 annual periods. Check 228760 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genomictree Inc. (2022–2022)
Year-by-year Capital Reinvestment Ratio for Genomictree Inc. from 2022 to 2022. For live market cap and broader valuation context, see Genomictree Inc. (228760) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.43x | ₩4.29 Billion | ₩1.82 Billion | — |